newsfilter
← Earnings
Earnings Releases·

Omnicell — Third Quarter 2026 Earnings Summary

  • Q3 2026 total revenue decreased 1% to $308 million year-over-year, while GAAP net income rose 120% to $11 million ($0.24/share) and Non-GAAP net income increased to $27 million ($0.58/share).
  • The company raised full-year 2026 Non-GAAP EBITDA guidance to $187–$193 million and Non-GAAP EPS to $2.48–$2.56, while tightening total revenue guidance to $1.225–$1.231 billion.
  • Management cited strong momentum from the next-generation platform (Titan XT and OmniSphere) and disciplined cost management as key drivers, noting Q3 results exceeded the high end of prior guidance.
  • Balance sheet strength remains robust with $315 million in cash, $169 million in total debt, and $350 million available under its revolving credit facility with no outstanding balance.
  • Full-year 2026 annual recurring revenue guidance is set at $660–$670 million, with Q4 revenue guidance established at $295–$301 million.
Company
OMNICELL INC
Sector
Healthcare
Industry
Health Information Services